Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Simon Couillard

Assistant-Professor, Respirologist, Clinician-Scientist

Université de Sherbrooke

Canada

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID Google Scholar

Research Interests

Immunology

40%

Epidemiology

30%

Respiratory Medicine

100%

Inflammatory Biology

70%

Respiratory Therapy

60%

Asthma

60%

Lung Disease

50%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Phenotyping Responses to Systemic Corticosteroids in the Management Asthma Attacks (PRISMA): microbiomic substudy

Open Date: 2023-01-01

Close Date: 2025-01-01

Grant: Close

Diagnostic and translational values of point-of-care blood eosinophils and exhaled nitric oxide (FeNO) in people referred by primary care for suspected asthma: a pilot study

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Diagnostic and translational values of point-of-care blood eosinophils and exhaled nitric oxide (FeNO) in people referred by primary care for suspected asthma: a pilot study

Open Date: 2023-01-01

Close Date: 2024-12-01

Grant: Close

Phenotyping Responses to Systemic Corticosteroids in the Management Asthma Attacks (PRISMA): Clinical and Translational Correlation to Type-2 Inflammatory Biomarkers

Open Date: 2022-08-01

Close Date: 2024-07-01

Grant: Open

Association Pulmonaire du Québec research chair for respiratory health

Open Date: 2022-06-01

Close Date: 2027-06-01

Simon Couillard

Assistant-Professor, Respirologist, Clinician-Scientist

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Recent Grants

Articles28

Normal FEV1 without Reversibility in Asthma Trials - A Placebo Patient-Level Meta-Analysis.

Baseline Membrane Thickness in Asthma: Where Type-2 Inflammation Meets Remodeling?

What Sex-Specific Differences Tells Us About Additive vs Synergistic Risk Prediction in Asthma

In the Land of Asthma, 4 Risk Factors to Rule Them All

Neuromodulation of dyspnea – A literature review

Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled randomised trial

Reply to: Type 2 inflammatory biomarkers in asthma and COPD: what we think we know

Smoking gun: when COPD therapies fail current smokers

Response

Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?

How I do it. Choosing the right biologic for the right patient with severe asthma

The carbon footprint of diagnostic delays in asthma

Acute chronic obstructive pulmonary disease (COPD) presentations with and without pneumonia: To lump or split, that is the question

Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist

Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023

Clinically accessible biomarkers to assess the modifiable risk of asthma/wheezing attacks in toddlers

The Lancet COPD Commission: broader questions remain

Exhaled nitric oxide (FeNO): Bridging a knowledge gap in asthma diagnosis and treatment

Predicting On-Biologic Remission in Asthma

Towards a Predict and Prevent Approach in Obstructive Airways Diseases

Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study

Are We Ready for Asthma Remission as a Clinical Outcome?

Canadian Thoracic Society Position Statement on Climate Change and Choice of Inhalers for Patients with Respiratory Disease

Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence

Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling

Collaborators11

Francine Ducharme

Richard Beasley

Erika Penz

Sanjay Ramakrishnan

Peter Howarth

Fiona Symon

Njira Lugogo

James Melhorn

Mary Jo Farmer

Ian Pavord

Timothy Hinks

How do I reach out?